All lobbying filings
MADRIGAL PHARMACEUTICALS, INC.
MADRIGAL PHARMACEUTICALS, INC. filed a Q4 report for MADRIGAL PHARMACEUTICALS, INC. on January 22, 2026.
Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 22, 2026
Expenses
$280,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Pennsylvania
Government bodies contacted
2
Lobbying activity
2
Issues related to CMMI drug pricing
Most Favored Nation drug pricing; Issues related to CMMI drug pricing